A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury.

[1]  S. Alexander,et al.  The role of adenosine receptors A2A and A2B signaling in renal fibrosis. , 2014, Kidney international.

[2]  A. Chadli,et al.  Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. , 2014, Pharmacological research.

[3]  G. Liou,et al.  ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. , 2013, Life sciences.

[4]  Liang-Yi Si,et al.  The effects of adenosine A2A receptor knockout on renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. , 2013, Acta histochemica.

[5]  Liang-Yi Si,et al.  Adenosine A2A Receptor: A Target for Regulating Renal Interstitial Fibrosis in Obstructive Nephropathy , 2013, PloS one.

[6]  C. Quezada,et al.  Targeting adenosine signaling to treatment of diabetic nephropathy. , 2013, Current drug targets.

[7]  Katarzyna Jaworska,et al.  Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. , 2012, The Journal of clinical investigation.

[8]  N. LeBrasseur,et al.  The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity , 2012, PloS one.

[9]  K. Ananthasubramaniam,et al.  A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease , 2012, Journal of Nuclear Cardiology.

[10]  M. Koupenova,et al.  A2b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis , 2012, Circulation.

[11]  J. Hughes,et al.  Adenosine A(2A) agonists as therapy for glomerulonephritis. , 2011, Kidney international.

[12]  L. Truong,et al.  Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation. , 2011, Kidney international.

[13]  Jean Wu,et al.  Osteopontin Overproduction Is Associated with Progression of Glomerular Fibrosis in a Rat Model of Anti-Glomerular Basement Membrane Glomerulonephritis , 2010, American Journal of Nephrology.

[14]  Chunxiang Zhang,et al.  Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Suszták,et al.  The role of osteopontin in the development of albuminuria. , 2008, Journal of the American Society of Nephrology : JASN.

[16]  P. Pacher,et al.  A2A receptors in inflammation and injury: lessons learned from transgenic animals , 2008, Journal of leukocyte biology.

[17]  L. Truong,et al.  Adenosine a 2a Receptor Activation and Macrophage- Mediated Experimental Glomerulonephritis This Protection against Acute and Chronic Inflammation Was Associated with Suppression of the Glomerular Expression of the Mdc/ccl22 Chemokine and Down-regulation of Mip-1␣/ccl3, Rantes/ccl5, Mip-1␤/ccl4, and , 2022 .

[18]  B. Blackburn,et al.  Regadenoson Pharmacokinetics and Tolerability in Subjects With Impaired Renal Function , 2007, Journal of clinical pharmacology.

[19]  Liping Huang,et al.  Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. , 2006, American journal of physiology. Renal physiology.

[20]  T. Pawełczyk,et al.  Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. , 2005, The American journal of pathology.

[21]  D. Liang,et al.  Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. , 2004, Diabetes.

[22]  Chih-Hung Lee,et al.  Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity. , 2003, Bioorganic & medicinal chemistry letters.

[23]  M. O'hare,et al.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.

[24]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[25]  A. O’Regan,et al.  Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation , 2000, International journal of experimental pathology.

[26]  R. Zeller,et al.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.

[27]  M S Spach,et al.  Conventional and confocal fluorescence microscopy of collagen fibers in the heart. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  D. Salant,et al.  Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. , 1985, The American journal of physiology.

[29]  T. Uejima,et al.  Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: analysis in Japanese patients. , 2013, Journal of cardiology.

[30]  J. Sedor,et al.  Activation of adenosine 2A receptors preserves structure and function of podocytes. , 2008, Journal of the American Society of Nephrology : JASN.

[31]  N. Nakao,et al.  Cytotoxicity of sera from rats with puromycin aminonucleoside nephrosis. , 1996, Nephron.

[32]  D. E. McCoy,et al.  The renal adenosine system: structure, function, and regulation. , 1993, Seminars in nephrology.